{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:11:34Z","timestamp":1772741494927,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study was conducted to identify potential biomarkers that could be used to evaluate disease progression and monitor responses to enzyme replacement therapy (ERT) in patients with mucopolysaccharidosis (MPS) IVA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Levels of 88 candidate biomarkers were compared in plasma samples from 50 healthy controls and 78 MPSIVA patients not receiving ERT to test for significant correlations to the presence of MPSIVA. MPSIVA samples were also tested for correlations between candidate biomarkers and age, endurance, or urinary keratin sulfate (KS) levels. Then, levels of the same 88 analytes were followed over 36 weeks in 20 MPSIVA patients receiving ERT to test for significant correlations related to ERT, age, or endurance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Nineteen candidate biomarkers were significantly different between MPSIVA and unaffected individuals. Of these, five also changed significantly in response to ERT: alpha-1-antitrypsin, eotaxin, lipoprotein(a), matrix metalloprotein (MMP)-2, and serum amyloid P. Three of these were significantly lower in MPSIVA individuals versus unaffected controls and were increased during ERT: alpha-1-antitrypsin, lipoprotein(a), and serum amyloid P.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Candidate biomarkers alpha-1-antitrypsin, lipoprotein(a), and serum amyloid P may be suitable markers, in addition to urinary KS, to follow the response to ERT in MPSIVA patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-1172-6-84","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T19:30:48Z","timestamp":1324063848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Biomarker analysis of Morquio syndrome: identification of disease state and drug responsive markers"],"prefix":"10.1186","volume":"6","author":[{"given":"Lisa","family":"Martell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik D","family":"Foehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,16]]},"reference":[{"key":"351_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","volume":"30","author":"AM Montano","year":"2007","unstructured":"Montano AM, Tomatsu S, Gottesman GS, Smith M, Orii T: International Morquio A Registry: Clinical manifestation and natural course of Morquio disease. J Inherit Metab Dis. 2007, 30: 165-174. 10.1007\/s10545-007-0529-7.","journal-title":"J Inherit Metab Dis"},{"key":"351_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cuor.2005.12.003","volume":"20","author":"BJA Lankaster","year":"2006","unstructured":"Lankaster BJA, Whitehouse M, Gargan MF: Morquio syndrome. Curr Orthop. 2006, 20: 128-131. 10.1016\/j.cuor.2005.12.003.","journal-title":"Curr Orthop"},{"key":"351_CR3","volume-title":"Poster presented at the Society of the Study of Inborn Errors of Metabolism (SSIEM) 2010 Meeting. Istanbul","author":"P Harmatz","year":"2010","unstructured":"Harmatz P, Chang M, Decker C: A multicenter, multinational, longitudinal clinical assessment study of subjects with mucopolysaccharidosis IVA (Morquio syndrome). Poster presented at the Society of the Study of Inborn Errors of Metabolism (SSIEM) 2010 Meeting. Istanbul. 2010."},{"key":"351_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3928\/00904481-20090723-09","volume":"38","author":"ER Lim-Melia","year":"2009","unstructured":"Lim-Melia ER, Kronn DF: Current enzyme replacement therapy for the treatment of lysosomal storage diseases. Pediatr Ann. 2009, 38: 448-455. 10.3928\/00904481-20090723-09.","journal-title":"Pediatr Ann"},{"key":"351_CR5","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","volume":"12","author":"S Tomatsu","year":"2003","unstructured":"Tomatsu S, Orii KO, Vogler C: Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns -\/-) produced by targeted disruption of the gene defective in Morquio A disease. Hum Mol Genet. 2003, 12: 3349-3358. 10.1093\/hmg\/ddg366.","journal-title":"Hum Mol Genet"},{"key":"351_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/hmg\/ddm353","volume":"17","author":"S Tomatsu","year":"2008","unstructured":"Tomatsu S, Montano A, Ohashi A: Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet. 2008, 17: 815-824.","journal-title":"Hum Mol Genet"},{"key":"351_CR7","unstructured":"BioMarin Pharmaceuticals Inc.: A phase 1\/2, multicenter, open-label, dose escalation study to evaluate the safety, tolerability, and efficacy of BMN110 in subjects with mucopolysaccharidosis IVA. Clinical study protocol, NCT00884949."},{"key":"351_CR8","unstructured":"BioMarin Pharmaceuticals Inc.: A double-blind study to evaluate the efficacy and safety of BMN110 in patients with mucopolysaccharidosis IVA. Clinical study protocol, NCT01275066."},{"key":"351_CR9","volume-title":"J Inherit Metab Dis","author":"S Tomatsu","year":"2010","unstructured":"Tomatsu S, Montano AM, Oguma T: Validation of keratin sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry. J Inherit Metab Dis. 2010."},{"issue":"8","key":"351_CR10","doi-asserted-by":"publisher","first-page":"e12194","DOI":"10.1371\/journal.pone.0012194","volume":"5","author":"M Dvorak-Ewell","year":"2010","unstructured":"Dvorak-Ewell M, Wendt D, Hague C: Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice. PLOS ONE. 2010, 5 (8): e12194. 10.1371\/journal.pone.0012194.","journal-title":"PLOS ONE"},{"key":"351_CR11","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.4155\/bio.11.172","volume":"3","author":"L Argento-Martell","year":"2011","unstructured":"Argento-Martell L, Cunico RL, Ohh J, Furneaux RH, Foehr ED: Validation of an LC\/MS\/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio syndrome. Bioanalysis. 2011, 3: 1855-1866. 10.4155\/bio.11.172.","journal-title":"Bioanalysis"},{"key":"351_CR12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1203\/01.PDR.0000113767.60140.E9","volume":"55","author":"S Tomatsu","year":"2004","unstructured":"Tomatsu S, Okamura K, Taketani T: Development and testing of a new screening method for keratan sulfate in mucopolysaccharidosis IVA. Pediatr Res. 2004, 55: 592-597. 10.1203\/01.PDR.0000113767.60140.E9.","journal-title":"Pediatr Res"},{"key":"351_CR13","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1167\/iovs.09-4914","volume":"51","author":"AH Conrad","year":"2010","unstructured":"Conrad AH, Zhang Y, Tasheva ES, Conrad GW: Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions. Invest Ophthamol Vis Sci. 2010, 51: 4500-4515. 10.1167\/iovs.09-4914.","journal-title":"Invest Ophthamol Vis Sci"},{"key":"351_CR14","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.2353\/ajpath.2009.090211","volume":"175","author":"S Wilson","year":"2009","unstructured":"Wilson S, Hashamiyan S, Clarke L: Collagenolytic activity in MPSI contributes to osteoclast and growth plate abnormalities. Am J Pathol. 2009, 175: 2053-2062. 10.2353\/ajpath.2009.090211.","journal-title":"Am J Pathol"},{"key":"351_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-3-16","volume":"3","author":"L Fregonese","year":"2008","unstructured":"Fregonese L, Stolk J: Hereditary alph-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008, 3: 16. 10.1186\/1750-1172-3-16.","journal-title":"Orphanet J Rare Dis"},{"key":"351_CR16","volume-title":"PLOS Patholog","author":"J Yuste","year":"2007","unstructured":"Yuste J, Botto M, Bottoms SE, Brown JS: Serum amyloid P aids complement mediated immunity to Streptococcus pneumonia. PLOS Patholog. 2007, 3: e120.doi:10."},{"key":"351_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MJT.0b013e3181e00bf1","volume":"17","author":"V Bermudez","year":"2010","unstructured":"Bermudez V, Arraiz N, Aparicio D: Lipoprotein(a): From molecules to therapeutics. Am J Ther. 2010, 17: 263-273. 10.1097\/MJT.0b013e3181e00bf1.","journal-title":"Am J Ther"},{"key":"351_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/ard.2008.101964","volume":"68","author":"E Choy","year":"2009","unstructured":"Choy E, Sattar N: Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk factors. Ann Rheum Dis. 2009, 68: 460-469. 10.1136\/ard.2008.101964.","journal-title":"Ann Rheum Dis"},{"key":"351_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/ar2471","volume":"10","author":"BH Hahn","year":"2008","unstructured":"Hahn BH, Grossman J, Ansell BJ: Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther. 2008, 10: 213. 10.1186\/ar2471.","journal-title":"Arthritis Res Ther"},{"key":"351_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/ard.2006.051672","volume":"66","author":"VP Van Halm","year":"2007","unstructured":"Van Halm VP, Nielen MM, Nurmohamed NT: Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 184-188.","journal-title":"Ann Rheum Dis"},{"key":"351_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1546-0096-7-18","volume":"7","author":"R Cimaz","year":"2009","unstructured":"Cimaz R, Coppa GV, Kone-Paut I: Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J. 2009, 7: 18. 10.1186\/1546-0096-7-18.","journal-title":"Pediatr Rheumatol Online J"},{"key":"351_CR22","volume-title":"Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI","author":"A Tessitore","year":"2009","unstructured":"Tessitore A, Pirozzi M, Auricchio A: Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI. Pathogenetics. 2009, 2 (4), doi:10.1186\/1755-8417-2-4."},{"key":"351_CR23","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.11390","volume":"48","author":"T-J Cho","year":"2003","unstructured":"Cho T-J, Lehmann W, Edgar C: Tumor necrosis factor alpha activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors. Arthitis Rheum. 2003, 48: 2845-2854. 10.1002\/art.11390.","journal-title":"Arthitis Rheum"},{"key":"351_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/01.bor.0000218950.27483.80","volume":"18","author":"KP Machold","year":"2006","unstructured":"Machold KP, Nell V, Stamm T, Aletaha D, Smolen JS: Early rheumatoid arthritis. Curr Opin Rheutmatol. 2006, 18: 282-288. 10.1097\/01.bor.0000218950.27483.80.","journal-title":"Curr Opin Rheutmatol"},{"key":"351_CR25","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1542\/peds.2009-1728","volume":"125","author":"O Gabrielli","year":"2010","unstructured":"Gabrielli O, Clarke LA, Bruni S, Coppa GV: Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up. Pediatrics. 2010, 125: e183-e187. 10.1542\/peds.2009-1728.","journal-title":"Pediatrics"},{"key":"351_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","volume":"77","author":"JJ McGill","year":"2010","unstructured":"McGill JJ, Inwood AC, Coman DJ: Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study. Clin Genet. 2010, 77: 492-498. 10.1111\/j.1399-0004.2009.01324.x.","journal-title":"Clin Genet"},{"key":"351_CR27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/MOP.0b013e3282f161f2","volume":"19","author":"TA Burrow","year":"2007","unstructured":"Burrow TA, Hopkin RJ, Leslie ND, Tinkle BT, Grabowski GA: Enzyme reconstitution\/replacement therapy for lysosomal storage diseases. Curr Opin Pediatr. 2007, 19: 628-635. 10.1097\/MOP.0b013e3282f161f2.","journal-title":"Curr Opin Pediatr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-6-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:13:04Z","timestamp":1630519984000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-6-84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["351"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-6-84","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"14 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"84"}}